Help us: Donate
Follow us on:
×

Menu

Back

Cyclarity Therapeutics

Organization Description

 

Cyclarity Therapeutics (formerly known as Underdog Pharmaceuticals), is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Team

Michael Kope

Cyclarity Therapeutics - CEO of Corporate Affairs

Matthew O'Connor, Ph.D.

Cyclarity Therapeutics - CEO of Scientific Affairs